Carta científica
Valoración de la utilidad de un suplemento multivitamínico estándar diseñado para pacientes con fibrosis quística
Evaluation of the usefulness of a standard multivitamin supplement designed for patients with cystic fibrosis
a Unidad de Fibrosis Quística, Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Madrid, España
b Unidad de Fibrosis Quística, Hospital Universitario Ramón y Cajal, Madrid, España
c Sección de Neumología Pediátrica, Unidad de Fibrosis Quística, Servicio de Pediatría, Hospital Universitario Ramón y Cajal, Madrid, España
d Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Hospital Universitario Ramón y Cajal, Madrid, España
e Servicio de Gastroenterología Pediátrica, Unidad de Fibrosis Quística, Hospital Universitario Ramón y Cajal, Madrid, España
f Facultad de Medicina, Universidad de Alcalá de Henares, Madrid, España
Leído
15152
Vecesse ha leído el artículo
2746
Total PDF
12406
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 7 | 99 | 18 | 117 |
| 2025 6 | 190 | 39 | 229 |
| 2025 5 | 222 | 34 | 256 |
| 2025 4 | 178 | 28 | 206 |
| 2025 3 | 168 | 26 | 194 |
| 2025 2 | 155 | 17 | 172 |
| 2025 1 | 127 | 25 | 152 |
| 2024 12 | 94 | 28 | 122 |
| 2024 11 | 89 | 51 | 140 |
| 2024 10 | 114 | 40 | 154 |
| 2024 9 | 99 | 25 | 124 |
| 2024 8 | 119 | 44 | 163 |
| 2024 7 | 143 | 40 | 183 |
| 2024 6 | 123 | 29 | 152 |
| 2024 5 | 115 | 38 | 153 |
| 2024 4 | 118 | 37 | 155 |
| 2024 3 | 129 | 29 | 158 |
| 2024 2 | 124 | 30 | 154 |
| 2024 1 | 149 | 34 | 183 |
| 2023 12 | 152 | 23 | 175 |
| 2023 11 | 178 | 31 | 209 |
| 2023 10 | 194 | 36 | 230 |
| 2023 9 | 140 | 30 | 170 |
| 2023 8 | 113 | 19 | 132 |
| 2023 7 | 118 | 24 | 142 |
| 2023 6 | 149 | 37 | 186 |
| 2023 5 | 153 | 29 | 182 |
| 2023 4 | 95 | 17 | 112 |
| 2023 3 | 93 | 24 | 117 |
| 2023 2 | 119 | 20 | 139 |
| 2022 1 | 76 | 31 | 107 |
| 2022 12 | 94 | 29 | 123 |
| 2022 11 | 116 | 34 | 150 |
| 2022 10 | 93 | 34 | 127 |
| 2022 9 | 110 | 34 | 144 |
| 2022 8 | 126 | 37 | 163 |
| 2022 7 | 62 | 30 | 92 |
| 2022 6 | 92 | 35 | 127 |
| 2022 5 | 94 | 23 | 117 |
| 2022 4 | 135 | 40 | 175 |
| 2022 3 | 141 | 56 | 197 |
| 2022 2 | 123 | 25 | 148 |
| 2021 1 | 125 | 38 | 163 |
| 2021 12 | 103 | 50 | 153 |
| 2021 11 | 88 | 42 | 130 |
| 2021 10 | 130 | 58 | 188 |
| 2021 9 | 110 | 36 | 146 |
| 2021 8 | 84 | 32 | 116 |
| 2021 7 | 95 | 34 | 129 |
| 2021 6 | 77 | 30 | 107 |
| 2021 5 | 109 | 54 | 163 |
| 2021 4 | 226 | 105 | 331 |
| 2021 3 | 223 | 44 | 267 |
| 2021 2 | 120 | 31 | 151 |
| 2020 1 | 134 | 31 | 165 |
| 2020 12 | 139 | 22 | 161 |
| 2020 11 | 177 | 33 | 210 |
| 2020 10 | 114 | 19 | 133 |
| 2020 9 | 350 | 36 | 386 |
| 2020 8 | 118 | 44 | 162 |
| 2020 7 | 171 | 34 | 205 |
| 2020 6 | 160 | 55 | 215 |
| 2020 5 | 121 | 33 | 154 |
| 2020 4 | 149 | 25 | 174 |
| 2020 3 | 124 | 23 | 147 |
| 2020 2 | 97 | 20 | 117 |
| 2020 1 | 113 | 27 | 140 |
| 2019 12 | 122 | 26 | 148 |
| 2019 11 | 132 | 29 | 161 |
| 2019 10 | 156 | 18 | 174 |
| 2019 9 | 169 | 40 | 209 |
| 2019 8 | 122 | 27 | 149 |
| 2019 7 | 109 | 19 | 128 |
| 2019 6 | 120 | 16 | 136 |
| 2019 5 | 149 | 23 | 172 |
| 2019 4 | 184 | 29 | 213 |
| 2019 3 | 210 | 24 | 234 |
| 2019 2 | 279 | 18 | 297 |
| 2019 1 | 71 | 20 | 91 |
| 2018 12 | 110 | 24 | 134 |
| 2018 11 | 96 | 18 | 114 |
| 2018 10 | 92 | 27 | 119 |
| 2018 9 | 48 | 11 | 59 |
| 2018 8 | 3 | 0 | 3 |
| 2018 7 | 4 | 0 | 4 |
| 2018 6 | 7 | 0 | 7 |
| 2018 5 | 16 | 0 | 16 |
| 2018 4 | 60 | 0 | 60 |
| 2018 3 | 50 | 0 | 50 |
| 2018 2 | 61 | 0 | 61 |
| 2018 1 | 50 | 0 | 50 |
| 2017 12 | 46 | 0 | 46 |
| 2017 11 | 42 | 0 | 42 |
| 2017 10 | 58 | 0 | 58 |
| 2017 9 | 45 | 0 | 45 |
| 2017 8 | 49 | 0 | 49 |
| 2017 7 | 54 | 0 | 54 |
| 2017 6 | 67 | 7 | 74 |
| 2017 5 | 75 | 4 | 79 |
| 2017 4 | 56 | 17 | 73 |
| 2017 3 | 66 | 2 | 68 |
| 2017 2 | 144 | 8 | 152 |
| 2016 1 | 58 | 3 | 61 |
| 2016 12 | 58 | 7 | 65 |
| 2016 11 | 88 | 21 | 109 |
| 2016 10 | 77 | 11 | 88 |
| 2016 9 | 115 | 16 | 131 |
| 2016 8 | 72 | 5 | 77 |
| 2016 7 | 38 | 10 | 48 |
Mostrar todo
